Bio Path Holdings Inc (NASDAQ:BPTH)
| 2.17 Delayed Data As of Feb 03 |  -0.06 / -2.70%Today’s Change | 1.27 Today|||52-Week Range 4.48 | +43.38% Year-to-Date |
Latest BPTH News | Press Releases
No recent news for Bio Path Holdings Inc.
Today’s Trading
| Previous close | 2.22 |
| Today’s open | 2.24 |
| Day’s range | 2.15 - 2.24 |
| Volume | 19,364 |
| Average volume (3 months) | 52,714 |
| Market cap | $17.6M |
Data as of 1:57pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +45.12% |
| Earnings growth (this year) | -19.03% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ITRMIterum Therapeutics ... | +0.03 | +1.72% |
| ONVOOrganovo Holdings In... | -0.06 | -3.74% |
| SNGXSoligenix Inc | +0.00 | +0.13% |
| HMTXFHemostemix Inc | +0.01 | +6.33% |
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | March 10, 2023 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$10.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bellaire, Texas |
Forecasts
